What is Ashwin Vasudevamurthy's specialty?

Ashwin Vasudevamurthy (NPI 1497998520) is a Medicare-billing provider whose primary specialty is Medical Oncology in Indianapolis, IN.

Where does Ashwin Vasudevamurthy practice?

Ashwin Vasudevamurthy practices in Indianapolis, IN, based on the location reported in the CMS Medicare provider datasets for NPI 1497998520.

How much does Medicare pay Ashwin Vasudevamurthy?

Ashwin Vasudevamurthy (NPI 1497998520) received approximately $1.6M in total Medicare Part B payments, serving 564 beneficiaries, per the CMS Medicare Physician & Other Practitioners dataset.

PROVIDER PROFILE · NPI 1497998520

Ashwin VasudevamurthyM.D.

PRACTICEAMERICAN ONCOLOGY PARTNERS, P.A.See all providers at this practice →

Medical OncologyIndianapolis, INI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,588

Unique beneficiaries

—

Total services

12,136

Distinct HCPCS

Medicare payment

$286K

Peer benchmark

Total Medicare services vs. 44 Medical Oncology providers in IN — top quintile (cohort median 1,399).

PRESCRIBING · PART D · 2024

Total Rx claims

1,096

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

Brand share

38.0%

Top prescribed drugs

Anastrozole211 claims

Apixaban104 claims

Zanubrutinib57 claims

Prednisone45 claims

Rivaroxaban41 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$12K

Payment records

142

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K

Food and Beverage$3K

Honoraria$2K

Travel and Lodging$1K

Consulting Fee$1K

Top paying entities

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K

Food and Beverage$3K

Honoraria$2K

Travel and Lodging$1K

Consulting Fee$1K

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history